降级(电信)
抗菌剂
氧化还原
化学
药品
组合化学
纳米技术
药理学
材料科学
有机化学
计算机科学
医学
电信
作者
Yue Zhang,Xuehan Yang,Yawei Zhao,Fangman Chen,Tongfei Shi,Ziping Wu,Xuenian Chen,Ming Zhang,Lixia Chen
标识
DOI:10.1016/j.colsurfb.2024.114308
摘要
The global crisis of antibiotic resistance has impelled the exigency to develop more effective drug delivery systems for the treatment of bacterial infection. The development of possessing high biocompatibility and targeted delivery of antimicrobials remains a persisting challenge. For programmable release of efficient antimicrobials in infection sites to enhance antibacterial activity, herein, we fabricated diselenide-bridged mesoporous organosilica nanoparticle-supported silver nanoparticles (Ag NPs) with high drug-loading capacity for the co-delivery of tobramycin (TOB) within one drug delivery system (Ag-MON@TOB (Se)). The resultant Ag-MON@TOB (Se) exhibited favorable biocompatibility due to its high stability in the physiological condition. Notably, such Ag-MON@TOB (Se) manifested a programmable structural destabilization to trigger sequential drug release in response to the oxidative stimuli within the bacterial infection microenvironment. In contradistinction to the oxidation-stable disulfide bond moieties within the framework of the nanocarrier (Ag-MON@TOB (S)), the Ag-MON@TOB (Se) with its programmed drug release behavior augmented prominent antibacterial therapy both in vitro and in vivo . This work represents a promising strategy for programmable drug release by harnessing a responsive degradable vehicle to enhance the treatment of bacterial infection. • Ag-MONs@TOB exhibits rapid degradation in the infected REDOX microenvironment, enabling simultaneous release of antimicrobials in time and space. Subsequently, the accelerated release of silver ions caused bacterial membrane damage, enhanced the permeability of TOB, and synergistic bactericidal activity. • Ag-MONs@TOB contains reduced chemical bonds that are specifically released during high levels of oxidative stress in bacterial infections. • Ag-MONs@TOB has good biocompatibility and ensures the biological safety and clinical application possibility at large doses.
科研通智能强力驱动
Strongly Powered by AbleSci AI